179 related articles for article (PubMed ID: 57447)
1. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
Reeve J; Hesp R; Williams D; Hulme P; Klenerman L; Zanelli JM; Darby AJ; Tregear GW; Parsons JA
Lancet; 1976 May; 1(7968):1035-8. PubMed ID: 57447
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
Slovik DM; Neer RM; Potts JT
J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
[TBL] [Abstract][Full Text] [Related]
3. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
Reeve J; Meunier PJ; Parsons JA; Bernat M; Bijvoet OL; Courpron P; Edouard C; Klenerman L; Neer RM; Renier JC; Slovik D; Vismans FJ; Potts JT
Br Med J; 1980 Jun; 280(6228):1340-4. PubMed ID: 6992932
[TBL] [Abstract][Full Text] [Related]
4. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
6. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
Dempster DW; Cosman F; Kurland ES; Zhou H; Nieves J; Woelfert L; Shane E; Plavetić K; Müller R; Bilezikian J; Lindsay R
J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
Riggs BL; Jowsey J; Goldsmith RS; Kelly PJ; Hoffman DL; Arnaud CD
J Clin Invest; 1972 Jul; 51(7):1659-63. PubMed ID: 4338118
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the parathyroids to create stronger bones.
Silver J; Bushinsky D
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):471-6. PubMed ID: 15199299
[TBL] [Abstract][Full Text] [Related]
9. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
Reeve J; Arlot M; Bernat M; Charhon S; Edouard C; Slovik D; Vismans FJ; Meunier PJ
Metab Bone Dis Relat Res; 1981; 3(1):23-30. PubMed ID: 7266363
[No Abstract] [Full Text] [Related]
10. Physiology of Parathyroid Hormone.
Goltzman D
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):743-758. PubMed ID: 30390810
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
13. The effects of sodium fluoride, calcium phosphate, and vitamin D2 for one to two years on calcium and phosphorus metabolism in postmenopausal women with spinal crush fracture osteoporosis.
Charles P; Mosekilde L; Jensen FT
Bone; 1985; 6(4):201-6. PubMed ID: 3876838
[TBL] [Abstract][Full Text] [Related]
14. The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis.
Fraser WD; Ahmad AM; Vora JP
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):437-44. PubMed ID: 15199294
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
16. [Deviations of calcium and phosphorus metabolism in postmenopausal osteoporosis].
Yoshikawa S
Nihon Rinsho; 1982; 40(12):2738-44. PubMed ID: 6761467
[No Abstract] [Full Text] [Related]
17. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
[TBL] [Abstract][Full Text] [Related]
19. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ;
N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
